NCI | Technology Transfer

Cross-Reactive Antibodies Against Dengue Viruses And Uses Thereof

Read more about Cross-Reactive Antibodies Against Dengue Viruses And Uses Thereof

Patent Cooperation Treaty
PCT/US13/40966
Filed on 2013-05-14

Nanoparticles with Enhanced Entry into Cancer Cells

Read more about Nanoparticles with Enhanced Entry into Cancer Cells

Patent Cooperation Treaty
PCT/US2013/041542
Filed on 2013-05-17

High-Affinity Monoclonal Antibodies To Glypican-3 And Use Thereof

Read more about High-Affinity Monoclonal Antibodies To Glypican-3 And Use Thereof

Patent Cooperation Treaty
PCT/US2013/043633
Filed on 2013-05-31

Pharmaceutical Composition Comprising NANOG SHRNA, and Method of Using NANOG SHRNA to Treat Cancer

Read more about Pharmaceutical Composition Comprising NANOG SHRNA, and Method of Using NANOG SHRNA to Treat Cancer

US Patent 9,163,236
Filed on 2013-08-02

Chimeric Rabbit/Human ROR1 Antibodies

Read more about Chimeric Rabbit/Human ROR1 Antibodies

US Patent 9,758,586
Filed on 2013-06-07

Chimeric Rabbit/Human ROR1 Antibodies

Read more about Chimeric Rabbit/Human ROR1 Antibodies

European Patent
11791733.6
Filed on 2011-11-30

Chimeric Rabbit/Human ROR1 Antibodies

Read more about Chimeric Rabbit/Human ROR1 Antibodies

Canada
2818992
Filed on 2011-11-30

Chimeric Rabbit/Human ROR1 Antibodies

Read more about Chimeric Rabbit/Human ROR1 Antibodies

Australia
2011336650
Filed on 2011-11-30

DIFFERENTIAL GENE EXPRESSION IN PHYSIOLOGICAL AND PATHOLOGICAL ANGIOGENESIS

Read more about DIFFERENTIAL GENE EXPRESSION IN PHYSIOLOGICAL AND PATHOLOGICAL ANGIOGENESIS

US Application 13/863,674
Filed on 2013-04-16

Alpha 1-3 N-Galactosylstransferase with Altered Donor Specificities, Compositions, and Methods of Use

Read more about Alpha 1-3 N-Galactosylstransferase with Altered Donor Specificities, Compositions, and Methods of Use

US Patent 9,222,080
Filed on 2013-04-11

Subscribe to NCI